Health X Platform Limited (NSE:HEALTHX)
India · Delayed Price · Currency is INR 300.85
-1.55 (-0.51%)
Aug 21, 2026, 3:29 PM IST
Health X Platform Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 14,677 | 13,059 | 10,881 | 13,548 | 10,369 | 6,230 |
Other Revenue | 457.24 | 716.07 | 627.46 | 766.05 | 237.3 | 157.1 |
| 15,134 | 13,775 | 11,509 | 14,314 | 10,607 | 6,387 | |
Revenue Growth | 26.48% | 19.70% | -19.60% | 34.95% | 66.06% | 15.97% |
Cost of Revenue | 14,512 | 12,924 | 10,722 | 12,844 | 10,085 | 6,281 |
Gross Profit | 622.01 | 851.69 | 786.66 | 1,470 | 521.76 | 105.77 |
Selling, General & Admin | - | - | 53.47 | 28.65 | 28.77 | 66.87 |
Other Operating Expenses | 830.31 | 790.15 | 773.41 | 811.48 | 698.71 | 443.18 |
Operating Expenses | 903.54 | 856.18 | 920.48 | 934.87 | 809.46 | 551.6 |
Operating Income | -281.53 | -4.49 | -133.82 | 534.97 | -287.7 | -445.83 |
Interest Expense | -12.9 | -7.82 | -2.17 | -10.09 | -8.68 | -16.2 |
Interest & Investment Income | - | - | 0.26 | 1.54 | 0.61 | 0.4 |
Earnings From Equity Investments | - | - | -108.04 | -861.77 | -848.98 | -51.86 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.66 |
EBT Excluding Unusual Items | -294.42 | -12.31 | -243.77 | -335.35 | -1,145 | -514.15 |
Gain (Loss) on Sale of Investments | - | - | 3.23 | - | -9.98 | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.64 | 11.5 | 0.01 |
Asset Writedown | - | - | -7.24 | - | - | - |
Other Unusual Items | -11.27 | -11.27 | -1,789 | 9.74 | -79.28 | 11,609 |
Pretax Income | -305.69 | -23.58 | -2,037 | -304.98 | -1,223 | 11,095 |
Income Tax Expense | -45.17 | -9.1 | -701.22 | -363.51 | -227.82 | 2,444 |
Earnings From Continuing Operations | -260.53 | -14.47 | -1,335 | 58.53 | -994.69 | 8,651 |
Minority Interest in Earnings | 58.57 | 26.23 | 423.76 | 30.3 | 272.59 | -2,383 |
Net Income | -201.95 | 11.76 | -911.67 | 88.83 | -722.11 | 6,268 |
Net Income to Common | -201.95 | 11.76 | -911.67 | 88.83 | -722.11 | 6,268 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change | -0.11% | -0.09% | - | - | - | - |
EPS (Basic) | -6.36 | 0.37 | -28.66 | 2.79 | -22.70 | 197.04 |
EPS (Diluted) | -6.36 | 0.37 | -28.66 | 2.79 | -22.70 | 197.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -887.61 | -276.65 | 216.34 | -1,315 | -2,119 |
Free Cash Flow Per Share | - | -27.93 | -8.70 | 6.80 | -41.33 | -66.61 |
Gross Margin | 4.11% | 6.18% | 6.83% | 10.27% | 4.92% | 1.66% |
Operating Margin | -1.86% | -0.03% | -1.16% | 3.74% | -2.71% | -6.98% |
Profit Margin | -1.33% | 0.08% | -7.92% | 0.62% | -6.81% | 98.14% |
Free Cash Flow Margin | - | -6.44% | -2.40% | 1.51% | -12.39% | -33.17% |
EBITDA | -212.5 | 61.54 | -79.78 | 605.83 | -223.96 | -412.29 |
EBITDA Margin | -1.40% | 0.45% | -0.69% | 4.23% | -2.11% | -6.46% |
D&A For EBITDA | 69.03 | 66.03 | 54.04 | 70.85 | 63.74 | 33.54 |
EBIT | -281.53 | -4.49 | -133.82 | 534.97 | -287.7 | -445.83 |
EBIT Margin | -1.86% | -0.03% | -1.16% | 3.74% | -2.71% | -6.98% |
Effective Tax Rate | - | - | - | - | - | 22.03% |
Revenue as Reported | 15,134 | 13,775 | 11,708 | 14,361 | 10,635 | 6,431 |
Advertising Expenses | - | - | 37.18 | 12.62 | 6.35 | 52.71 |